Target intelligence / Profile preview

Plasma membrane H+-ATPase (Pma1p) (Pma1p)

Target
Pma1p
Molecular classification
Enzyme, Transporter, P-type ATPase
01

Overview

The Saccharomyces cerevisiae H+-ATPase, primarily the Pma1p isoform, is an essential P-type ATPase that serves as the major proton pump in the yeast plasma membrane (UniProt P05030). It utilizes the energy from ATP hydrolysis to export protons from the cytoplasm to the extracellular space, a process vital for maintaining intracellular pH homeostasis and generating a large electrochemical gradient across the membrane (Serrano et al., 1986, Nature). This proton motive force is the primary driver for the secondary active transport of essential nutrients, including amino acids and sugars, into the cell (Perlin et al., 1997, J. Biol. Chem.). Because Pma1p is essential for fungal viability and lacks a direct structural ortholog in the human plasma membrane, it is a highly attractive target for the development of novel antifungal therapeutics (Monk et al., 1995, Antimicrob. Agents Chemother.). Pharmacological inhibition of this enzyme by compounds such as ebselen or certain proton pump inhibitors leads to rapid cytosolic acidification, dissipation of the membrane potential, and subsequent growth arrest or cell death (Chan et al., 2007, J. Biol. Chem.). Research into this target is particularly relevant for addressing drug-resistant fungal pathogens like Candida species, which utilize similar H+-ATPase mechanisms for survival and virulence.

Other names
PMA1Proton-exporting ATPaseP-type ATPaseH(+)-transporting ATPaseYGL008CAdenosine triphosphatase
02

Mechanism of action

Inhibition of ATP-dependent proton extrusion leading to intracellular acidification and loss of the electrochemical gradient.

03

Biological functions

Intracellular pH regulationMembrane potential maintenanceSecondary active transportCation homeostasis
04

Disease associations

Fungal infectionCandidiasisMycosis
05

Safety considerations

Selectivity against human P-type ATPases (e.g., Na+/K+-ATPase and gastric H+/K+-ATPase)Potential for mitochondrial toxicity if off-target effects occurSpecies-specific structural variations in the P-type ATPase family
06

Interacting drugs

Ebselen

5 more in the full profile.

07

Biomarkers

Intracellular pH (pHi)Extracellular acidification rate (ECAR)Cytosolic ATP/ADP ratio

Beyond the preview

Go deeper on Plasma membrane H+-ATPase (Pma1p) (Pma1p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane H+-ATPase (Pma1p) (Pma1p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call